News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Solid Lymphoma Data Points To Larger Potential For Epizyme, Says Citi     11/20/2014
AstraZeneca PLC Shows Off Strong Drug Pipeline As Pfizer Deadline Looms     11/18/2014
Pfizer, Merck KGaA Strike A $2.9B Deal To Develop Cancer Tumor Treatment     11/18/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Merck & Co. Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma     11/17/2014
Puma Biotechnology's Cancer Drug Neratinib Fails Mid-Stage Study     11/14/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA), BioMarin Pharmaceutical Inc. and Tesaro, Inc. To Most Preferred     11/14/2014
Gilead Sciences, Inc. Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst     11/11/2014
Citi: Esperion Therapeutics, Inc. Will See Cancer Drug Data By End Of Year     11/11/2014
Analyst: Celgene’s Drug Pipeline Will Be The Gift That Keeps On Giving     11/10/2014
Citi: Agios Pharmaceuticals’s Experimental Cancer Drug Could Provide Major Upside     11/10/2014
Novartis AG's Panobinostat Fails To Win FDA Panel Support     11/7/2014
Bristol-Myers Squibb Company, Merck & Co. Competing Hodgkin’s Drugs Look Comparable, Says Analyst     11/7/2014
Pharmacyclics, Inc., AstraZeneca PLC Partnership Holds Tumor Promise: Citi     11/6/2014
Amgen, Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst     10/31/2014

Featured Stories
The Dirty Side Of Soap, University of California, San Diego (UCSD) Study     11/19/2014
Walnuts Slow Prostate Cancer In Mice, University of California, Davis (UCD) Study     11/18/2014
University of North Carolina Researchers Silence Leading Cancer-Causing Gene     11/18/2014
Lactose Intolerants Linked To Lower Cancer Risk, Lund University Study     11/6/2014
Long Term Shift Work Linked To Impaired Brain Function, Occupational & Environmental Medicine Reveals     11/5/2014
Saliva May Reveal Deadly Diseases Early Enough To Treat Them, University of California, Los Angeles (UCLA) Scientists Report     10/31/2014
Tea And Citrus Products Could Lower Ovarian Cancer Risk, New University of East Anglia Research Finds     10/29/2014
Finally: A Missing Link Between Vitamin D and Prostate Cancer, University of Colorado Study     10/24/2014
Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study     10/23/2014
Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study     10/21/2014
Thyroid Carcinoma: Biomarker Reveals Cancer Cause, Helmholtz Zentrum Munchen Study     10/14/2014
Americans Living Longer As Fewer Die From Heart Disease, Cancer, CDC Reveals     10/13/2014
Hormone That Keeps Us Alert Also Suppresses The Spread Of Cancer, Weizmann Institute of Science Reveals     10/9/2014
New Blood Test Shows Who Has And Who May Get Cancer, University Of Bradford Study     10/3/2014
Tattoo Ink Linked To Skin Cancer Risk, PRS Global Open Reveals     9/23/2014

More News
Polaris Group Announces Treatment Of First Patient In Phase 1 Study Of ADI-PEG 20 Plus Pemetrexed And Cisplatin In Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma     11/20/2014
Tokai Pharmaceuticals (TKAI) Presents Updated Interim Galeterone ARMOR2 Data Showing Activity In Patients With Castration-Resistant Prostate Cancer (CRPC) Including Those Showing A Variant Form Of Prostate Cancer Resistant To Hormone Therapy     11/19/2014
Puma Biotechnology (PBYI) Announces Positive Top Line Results From PB272 Phase 2 Trial In HER2 Positive Metastatic Breast Cancer (Nefertt Trial)     11/14/2014
Celiac Disease Center At Columbia University Unveils Video Campaign At 13th Anniversary Gala To Demonstrate The Severity Of Celiac Disease For Patients     11/14/2014
MaxiVAX SA Release: Swiss Biotech Starts Breakthrough Anti-Cancer Clinical Trial Based On Active Immunotherapy     11/13/2014
Quiet Therapeutics Co-Founders Prof Dan Peer And Prof Rimona Margalit Receive Award For Groundbreaking Work In Targeted Nanoparticles For Cancer     11/13/2014
Caris Life Sciences Study Shows Molecular Profiling May Expand Use Of PD-1 And PD-L1 Inhibitors To Wide Variety Of Cancers     11/12/2014
Biothera’s Imprime PGG Named To Top 10 List Of Most Interesting Oncology Projects To Watch     11/12/2014
NovoCure Ltd. Announces The Presentation Of New Data At The 19th Annual Society Of Neuro-Oncology Meeting     11/11/2014
Children's Hospital of Philadelphia Release: Classification Of Gene Mutations In A Children's Cancer May Point To Improved Treatments     11/10/2014
Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options     11/10/2014
Multiple Bristol-Myers Squibb Company (BMY) Oncology Compounds To Be Featured In Oral Presentations At 56th Annual American Society of Hematology Meeting     11/10/2014
Seattle Children's Research Institute's Begins Recruiting Patients For Immunotherapy Research Trial For Neuroblastoma, One Of The Deadliest Forms Of Childhood Cancer     11/7/2014
Lycera Announces Research Showing Novel, Oral Immunotherapy Possesses Potent Single Agent Anti-Cancer Activity     11/7/2014
Exelixis, Inc. (EXEL) Completes Enrollment Of The METEOR Phase 3 Pivotal Trial Of Cabozantinib In Metastatic Renal Cell Carcinoma     11/6/2014